NURS660 Psychopharmacology
Exam 4 - ADHD, Dementia,
Impulsivity/Compulsivity, And
Addiction. Q&A
EXAM
Q1: The cortico-striatal-thalamic (CSTC) loop modulates motor
activity through connections from the prefrontal motor cortex to
which structure?
A. Caudate nucleus
B. Putamen (lateral striatum)
C. Globus pallidus interna
D. Subthalamic nucleus
A1: B. Putamen (lateral striatum).
Rationale: The CSTC loop involved in motor activity
(hyperactivity) connects the prefrontal motor cortex to the
putamen, then to the thalamus, and back to the cortex.
Q2: A 9-year-old boy is constantly fidgeting, leaves his seat in
class, runs excessively, and has trouble playing quietly. These
symptoms are primarily mediated by dysfunction in which brain
pathway?
A. Cortico-striatal-thalamic loop
B. Mesolimbic dopamine pathway
C. Mesocortical pathway
D. Nigrostriatal pathway
,A2: A. Cortico-striatal-thalamic loop.
Rationale: Hyperactivity symptoms in ADHD are modulated
by the CSTC loop from the prefrontal motor cortex to the
putamen.
Q3: A child with ADHD has significant issues with distractibility,
forgetfulness, and fatigue. This presentation is most associated
with deficiency of which neurotransmitters?
A. Serotonin and GABA
B. Norepinephrine and dopamine
C. Acetylcholine and histamine
D. Glutamate and glycine
A3: B. Norepinephrine and dopamine.
Rationale: ADHD involves dysregulation of dopamine and
norepinephrine. Low levels contribute to inattention and
fatigue.
Q4: The pathophysiology of ADHD is best described as:
A. Excessive dopamine in the nucleus accumbens
B. Overactivity of the default mode network
C. Inefficient tuning of the prefrontal cortex by dysregulation
of dopamine and norepinephrine
D. Decreased serotonin transmission in the raphe nuclei
A4: C. Inefficient tuning of the prefrontal cortex by dysregulation
of dopamine and norepinephrine.
, Rationale: ADHD results from inefficient prefrontal cortex
modulation due to dysregulation of dopamine and
norepinephrine, leading to inattention, hyperactivity, and
impulsivity.
Q5: Which medication for ADHD is a non-stimulant that inhibits
the norepinephrine transporter (NET) in the prefrontal cortex?
A. Methylphenidate
B. Dextroamphetamine
C. Atomoxetine
D. Guanfacine
A5: C. Atomoxetine.
Rationale: Atomoxetine (Strattera) is a selective
norepinephrine reuptake inhibitor (NRI).
Q6: A patient with ADHD and comorbid anxiety would benefit
most from which non-stimulant that also reduces blood pressure?
A. Bupropion
B. Atomoxetine
C. Guanfacine extended-release
D. Modafinil
A6: C. Guanfacine extended-release.
Rationale: Guanfacine (Intuniv) is an alpha-2A agonist
approved for ADHD that also lowers blood pressure and may
reduce anxiety.
, Q7: Which statement accurately distinguishes the mechanism of
amphetamine from methylphenidate? (Select all that apply)
A. Amphetamine promotes the release of dopamine and
norepinephrine.
B. Methylphenidate only blocks the reuptake of
norepinephrine and dopamine.
C. Both amphetamine and methylphenidate only block
reuptake.
D. Methylphenidate promotes the release of dopamine.
A7: A & B.
Rationale: Amphetamines promote release and inhibit
reuptake of dopamine and norepinephrine. Methylphenidate
primarily blocks the reuptake of these neurotransmitters. This
distinction is key for understanding their pharmacology.
Q8: A 7-year-old with ADHD cannot swallow pills. Which
formulation of methylphenidate can be opened and sprinkled on
food?
A. Ritalin (immediate-release)
B. Concerta
C. Ritalin LA (long-acting capsules)
D. Daytrana patch
A8: C. Ritalin LA (long-acting capsules).
Rationale: Ritalin LA and other long-acting methylphenidate
capsules contain beads that can be sprinkled on soft foods
for patients who have difficulty swallowing pills. Concerta
tablets must be swallowed whole.
Exam 4 - ADHD, Dementia,
Impulsivity/Compulsivity, And
Addiction. Q&A
EXAM
Q1: The cortico-striatal-thalamic (CSTC) loop modulates motor
activity through connections from the prefrontal motor cortex to
which structure?
A. Caudate nucleus
B. Putamen (lateral striatum)
C. Globus pallidus interna
D. Subthalamic nucleus
A1: B. Putamen (lateral striatum).
Rationale: The CSTC loop involved in motor activity
(hyperactivity) connects the prefrontal motor cortex to the
putamen, then to the thalamus, and back to the cortex.
Q2: A 9-year-old boy is constantly fidgeting, leaves his seat in
class, runs excessively, and has trouble playing quietly. These
symptoms are primarily mediated by dysfunction in which brain
pathway?
A. Cortico-striatal-thalamic loop
B. Mesolimbic dopamine pathway
C. Mesocortical pathway
D. Nigrostriatal pathway
,A2: A. Cortico-striatal-thalamic loop.
Rationale: Hyperactivity symptoms in ADHD are modulated
by the CSTC loop from the prefrontal motor cortex to the
putamen.
Q3: A child with ADHD has significant issues with distractibility,
forgetfulness, and fatigue. This presentation is most associated
with deficiency of which neurotransmitters?
A. Serotonin and GABA
B. Norepinephrine and dopamine
C. Acetylcholine and histamine
D. Glutamate and glycine
A3: B. Norepinephrine and dopamine.
Rationale: ADHD involves dysregulation of dopamine and
norepinephrine. Low levels contribute to inattention and
fatigue.
Q4: The pathophysiology of ADHD is best described as:
A. Excessive dopamine in the nucleus accumbens
B. Overactivity of the default mode network
C. Inefficient tuning of the prefrontal cortex by dysregulation
of dopamine and norepinephrine
D. Decreased serotonin transmission in the raphe nuclei
A4: C. Inefficient tuning of the prefrontal cortex by dysregulation
of dopamine and norepinephrine.
, Rationale: ADHD results from inefficient prefrontal cortex
modulation due to dysregulation of dopamine and
norepinephrine, leading to inattention, hyperactivity, and
impulsivity.
Q5: Which medication for ADHD is a non-stimulant that inhibits
the norepinephrine transporter (NET) in the prefrontal cortex?
A. Methylphenidate
B. Dextroamphetamine
C. Atomoxetine
D. Guanfacine
A5: C. Atomoxetine.
Rationale: Atomoxetine (Strattera) is a selective
norepinephrine reuptake inhibitor (NRI).
Q6: A patient with ADHD and comorbid anxiety would benefit
most from which non-stimulant that also reduces blood pressure?
A. Bupropion
B. Atomoxetine
C. Guanfacine extended-release
D. Modafinil
A6: C. Guanfacine extended-release.
Rationale: Guanfacine (Intuniv) is an alpha-2A agonist
approved for ADHD that also lowers blood pressure and may
reduce anxiety.
, Q7: Which statement accurately distinguishes the mechanism of
amphetamine from methylphenidate? (Select all that apply)
A. Amphetamine promotes the release of dopamine and
norepinephrine.
B. Methylphenidate only blocks the reuptake of
norepinephrine and dopamine.
C. Both amphetamine and methylphenidate only block
reuptake.
D. Methylphenidate promotes the release of dopamine.
A7: A & B.
Rationale: Amphetamines promote release and inhibit
reuptake of dopamine and norepinephrine. Methylphenidate
primarily blocks the reuptake of these neurotransmitters. This
distinction is key for understanding their pharmacology.
Q8: A 7-year-old with ADHD cannot swallow pills. Which
formulation of methylphenidate can be opened and sprinkled on
food?
A. Ritalin (immediate-release)
B. Concerta
C. Ritalin LA (long-acting capsules)
D. Daytrana patch
A8: C. Ritalin LA (long-acting capsules).
Rationale: Ritalin LA and other long-acting methylphenidate
capsules contain beads that can be sprinkled on soft foods
for patients who have difficulty swallowing pills. Concerta
tablets must be swallowed whole.